BioVenture Capstone Executive by Brown
Log in

Command the Full Biotech Value Chain

BioVenture Capstone Executive is the rigorous, portfolio-driven program that takes senior life-science professionals from functional expert to enterprise strategist — mastering venture formation, global commercialization, AI governance, and investor-ready leadership in a single, integrated curriculum.

27 lessonsAI-adaptiveCancel anytimeLearn anywhere
BioVenture Capstone Executive by Brown Tech Academy Industry

"I built this program around one conviction: the biotechnology executives who will shape the next decade are the ones who master strategy, governance, and capital fluency now — not later."

Pauline B. Smith, EdD

What you'll learn

What you'll be able to do

  • Build and present an investor-ready biotech venture formation plan with defensible financial projections and IP strategy
  • Design a global commercialization roadmap including market access, reimbursement pathways, and competitive intelligence
  • Develop an AI governance framework and digital transformation strategy tailored to a biotechnology enterprise
  • Construct a comprehensive executive portfolio with dashboards, innovation scorecards, and organizational transformation plans
  • Lead enterprise risk management and regulatory preparedness assessments across international markets
  • Demonstrate executive competency through simulated investor pitch exercises, governance planning, and evidence-based strategic decisions

How it works

A school that adapts to you

This isn't a set of static videos. Every lesson is generated live and tuned to where you actually are.

We learn your level

A quick placement check tailors your starting point so you're never bored or lost.

Lessons adapt as you go

Each lesson is written for your pace and your goal, adjusting as your skills grow.

Your AI coach keeps you moving

Checkpoints, feedback, and gentle nudges turn progress into a real result.

The curriculum

What's inside your school

0 modules · 0 lessons

1

Biotech Venture Formation and Entrepreneurial Strategy

Covers the foundational mechanics of launching a biotechnology venture — from opportunity identification and legal entity formation to IP strategy and early-stage financial modeling.

  • 1.1Identifying and Validating Biotechnology OpportunitiesIncluded
  • 1.2Legal Entity Formation and Governance StructuresIncluded
  • 1.3Intellectual Property Strategy and Patent Portfolio PlanningIncluded
  • 1.4Early-Stage Financial Modeling and ProjectionsIncluded
  • 1.5Developing an Investor-Ready Venture Formation PlanIncluded
2

Commercialization Strategy and Global Market Expansion

Guides executives through designing and executing a global commercialization roadmap, including market access, reimbursement, competitive intelligence, and international regulatory strategy.

  • 2.1Commercialization Roadmap Design and Milestone PlanningIncluded
  • 2.2Market Access, Pricing, and Reimbursement PathwaysIncluded
  • 2.3Competitive Intelligence and Strategic PositioningIncluded
  • 2.4Global Regulatory Preparedness and International Market EntryIncluded
  • 2.5Designing the Global Commercialization Roadmap and Growth PlanIncluded
3

Financing, Investment Strategy, and Investor Readiness

Prepares executives to architect a full financing strategy — spanning venture capital, strategic partnerships, non-dilutive funding, and investor pitch mastery.

  • 3.1Biotech Financing Landscape: Equity, Debt, and Non-Dilutive CapitalIncluded
  • 3.2Valuation Methods and Deal Structure in Life SciencesIncluded
  • 3.3Building the Investor Pitch and Due Diligence PackageIncluded
  • 3.4Simulated Investor Pitch and Negotiation ExerciseIncluded
4

Strategic Partnerships, Licensing, and Alliance Management

Equips leaders to identify, structure, and manage high-value strategic partnerships, licensing deals, and co-development alliances that accelerate commercialization.

  • 4.1Identifying and Evaluating Strategic Partnership OpportunitiesIncluded
  • 4.2Licensing, Co-Development, and Alliance Deal StructuringIncluded
  • 4.3Managing Alliances and Measuring Partnership PerformanceIncluded
5

Digital Transformation, AI Governance, and Innovation Leadership

Builds executive capability to lead enterprise-wide digital transformation — deploying AI, cloud analytics, and automation responsibly within a robust governance framework.

  • 5.1Digital Transformation Strategy for Biotechnology EnterprisesIncluded
  • 5.2Artificial Intelligence Applications Across the Biotech Value ChainIncluded
  • 5.3Building an AI Governance Framework and Ethics PolicyIncluded
  • 5.4Workforce Readiness and Organizational Capability BuildingIncluded
  • 5.5Innovation Scorecard and Digital Enterprise Strategy DeliverableIncluded
6

Enterprise Risk, Executive Governance, and Capstone Portfolio

Culminates the program by integrating enterprise risk management, executive performance systems, and a complete master portfolio that demonstrates credential-level executive competency.

  • 6.1Enterprise Risk Management and Cybersecurity ResilienceIncluded
  • 6.2Executive Performance Dashboards and Strategic KPI DesignIncluded
  • 6.3Organizational Readiness and Scalability AssessmentIncluded
  • 6.4Executive Capstone: Integrated Strategy PresentationIncluded
  • 6.5Master Executive Portfolio Review and Credential VerificationIncluded

Who it's for

Is this you?

R&D Directors

Deep in pipeline leadership but ready to command the full commercial and governance agenda that comes with a C-suite mandate.

Life-Science Entrepreneurs

Building or preparing to launch a biotech venture and needing the investor-ready frameworks, IP strategy, and financial modeling to compete at the institutional level.

VP-Level Commercial Leaders

Experienced in launch execution but seeking the enterprise strategy fluency — global market access, AI governance, partnership structuring — required to step into a Chief Commercial Officer role.

Regulatory & Market Access Executives

Expert in navigating single-market frameworks and ready to architect multi-jurisdictional regulatory and reimbursement strategies at a global scale.

Aspiring Biotech C-Suite

Targeting a CEO, COO, or Chief Strategy Officer role and building the executive portfolio, governance fluency, and investor-facing credibility to make that transition defensible.

Strategic Partnership Leaders

Negotiating licensing and alliance deals today, but ready to own the full enterprise partnership strategy — from deal structuring and co-development frameworks to performance measurement and value capture.

Questions

Frequently asked

Your teacher

A note from your teacher

Pauline B. Smith, EdD

Pauline B. Smith, EdD

If you have spent years building deep expertise inside biotechnology — navigating IND filings, managing platform assets, leading commercial launches, or steering R&D portfolios — you already know that technical credibility is necessary but not sufficient at the executive level. The questions that determine outcomes at that level are different: How do you structure a venture for institutional investment? How do you design a reimbursement strategy across jurisdictions where the rules are not the same? How do you govern an AI deployment inside a regulated organization without creating liability exposure? How do you walk into a Series B negotiation and defend your valuation assumptions without blinking?

Those are not questions answered by another conference or another elective. They are answered by structured, rigorous work — the kind that forces you to build the actual document, defend the actual number, and present to a room that has seen every weak assumption before. That is what BioVenture Capstone Executive is built around.

This program exists because the biotechnology industry is operating at a level of strategic complexity that demands a new kind of executive — one who can hold scientific credibility and enterprise governance fluency simultaneously. The commercial landscape has changed. Capital allocation has changed. AI is reshaping the value chain faster than most governance structures can absorb. Regulatory environments are diverging internationally in ways that require proactive strategy, not reactive compliance. The leaders who will define this industry's next decade are the ones who build the frameworks now.

Every deliverable in this curriculum was designed to be used — not submitted and forgotten. Your venture formation plan, your global commercialization roadmap, your AI governance framework, your executive portfolio: these are working documents. They are the artifacts of executive thinking that you bring into your next capital conversation, your next board presentation, or your next venture. I designed BioVenture Capstone Executive to close the gap between where you are and where the industry needs you to be.

If you are ready to do the work at that level, I am ready to guide you through it. The seat at the table you are aiming for does not come from tenure alone — it comes from demonstrated strategic capability. Let's build yours.

Pauline B. Smith, EdD

Start your journey today

Get instant access — learn at your own pace with an AI coach in your corner.

$197/mo

Recurring billing · cancel anytime

Secure checkout · Instant access

  • 6 modules, 27 lessons
  • AI-adaptive lessons tuned to your level
  • Quizzes & checkpoints to lock in progress
  • Your own AI learning coach
  • Learn on any device, at your pace
  • Full access for as long as you're subscribed